Evaluation of the Efficacy of Potassium Iodide Preparation for Radioactive Iodine Therapy in Graves Disease: A Retrospective Chart Review

Seigo Tachibana, Hiroyuki Yamashita, Toshihiko Yanase


Background: Pretreatment by antithyroid drugs (ATDs) before radioactive iodine therapy (RAIT) for Graves disease (GD) is often performed to avoid aggravation of thyroid function including thyroid storm. However, in patients suffering from adverse effects of ATDs, potassium iodide (KI) is often selected to treat hyperthyroidism before RAIT in Japan. The aim of this study was to evaluate the efficacy of KI preparation for RAIT in GD and whether a short-term discontinuation of KI before RAIT is a safe and useful method in GD patients showing adverse effects from ATDs.

Methods: This is a retrospective chart review. The 24 patients enrolled in this study were divided into two groups. Patients who had large goiter and/or underwent previous RAIT were excluded. Before RAIT, 11 patients were administered KI and were referred to as the KI group. The remaining 13 patients were administered methimazole (MMI) and referred to as the MMI group. Between these two groups, the following factors were compared; radioactive iodine uptake (RAIU) before RAIT, thyroid gland weight, dose of administered 131-I, dose of 131-I based on thyroid gland weight, free thyroxine (FT4) at RAIT, difference in FT4 between before and 4 days after discontinuation of drugs, and thyroid function and thyroid gland weight 1 year after RAIT.

Results: RAIU before RAIT (P = 0.0018), dose of 131-I (P = 0.0037), FT4 at RAIT (P = 0.0034), and thyroid gland weight 1 year after RAIT (P = 0.0065) showed significant differences. Thyroid gland weight, dose of 131-I based on thyroid gland weight, difference in FT4 between before drug discontinuation and at RAIT, and thyroid function at 1 year after RAIT did not show any significant differences.

Conclusion: These results suggest that most patients without large goiter and/or highly aggressive disease may be safely and efficiently treated with RAIT and KI pretreatment until 4 days before therapy.

J Endocrinol Metab. 2017;7(1):25-30
doi: https://doi.org/10.14740/jem394w


Gravesí disease; Radioactive iodine therapy; Potassium iodide; Antithyroid drug

Full Text: HTML PDF

Browse  Journals  


Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics


World Journal of Oncology

Gastroenterology Research

Journal of Hematology


Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity


Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research


Journal of Neurology Research

International Journal of Clinical Pediatrics



Journal of Endocrinology and Metabolism, bimonthly, ISSN 1923-2861 (print), 1923-287X (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)

This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.jofem.org   editorial contact: editor@jofem.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.

Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.